Nobell Foods

PUBLIC

Name	Nobell Foods (now operating as Alpine Bio)
Tagline	Engineers dairy proteins in plants to create plant-based cheese and dairy alternatives that match conventional cheese.
Headquarters	San Francisco, United States
Founded	2016
Stage	Series B
Business Model	B2C
Industry	Agtech
Technology	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding Label	$100M+ (total disclosed ~$102.5M)

Links

PUBLIC

• Website: https://www.nobellfoods.com/
• LinkedIn: https://www.linkedin.com/company/nobellfoods

Executive Summary

PUBLIC Nobell Foods, now operating as Alpine Bio, is a food-tech company engineering dairy proteins directly in plants to create cheese alternatives that aim to match conventional dairy on taste, texture, and price, a proposition that has secured over $100 million in venture backing from a syndicate of top-tier climate and technology investors [Bloomberg, July 2021][TechCrunch, July 2021]. The company's founding story is rooted in founder Magi Richani's personal experience with lactose intolerance, which led her to leave a project engineering role at Shell in 2016 to pursue a solution [Fast Company, July 2021]. Its core differentiation lies in a patented platform that uses soybeans as bioreactors to produce casein, the key protein responsible for cheese's melt and stretch, moving beyond the starch-and-oil formulations that have limited consumer adoption of plant-based cheese [Nobell Foods][Tracxn].

Richani, the solo founder and CEO, brings an engineering mindset from her prior industry experience, though her public record does not yet show a prior food science or CPG leadership role before founding the company [Fast Company, July 2021]. The business model is B2C, targeting mainstream consumers and foodservice buyers with products designed for no-compromise substitution, funded primarily by a $75 million Series B round in mid-2021 led by Breakthrough Energy Ventures [SPEEDA Edge]. Over the next 12-18 months, the critical milestones to watch are the commercial launch of its first product, animal-free mozzarella, slated for public tastings in 2025, and the progress of its self-affirmed GRAS (Generally Recognized as Safe) certification for plant-derived casein in the US, which is necessary for broad market entry [AgFunderNews][Green Queen].

Data Accuracy: GREEN -- Core company claims and funding round details corroborated by multiple independent news sources and investor profiles.

Taxonomy Snapshot

Axis	Classification
Stage	Series B
Business Model	B2C
Industry / Vertical	Agtech
Technology Type	Biotech / Life Sciences
Geography	North America
Growth Profile	Venture Scale
Founding Team	Solo Founder
Funding	$100M+ (total disclosed ~$102,540,000)

Company Overview

PUBLIC Nobell Foods was founded in 2016 by Magi Richani, a project engineer who left her role at Shell to pursue the challenge of creating a plant-based cheese that did not compromise on taste or texture [Fast Company, July 2021]. The company is headquartered in San Francisco, California, and operates under the brand Nobell Foods, with a recent strategic rebranding to Alpine Bio signaling an expansion of its platform [AgFunderNews] [Green Queen].

Richani's personal experience with lactose intolerance served as a primary motivator, driving the company's mission to engineer dairy proteins directly in plants for mainstream consumers [The Times Tech Podcast]. The core technological breakthrough, developing soybeans that express casein proteins, was achieved in the years following its founding, leading to the company's first patent and the harvest of its casein-containing soybeans in 2024 [GFI, 2025].

Key corporate milestones are anchored by its significant Series B financing. In July 2021, the company raised $75 million in a round led by Breakthrough Energy Ventures, with participation from Andreessen Horowitz and other notable investors [Bloomberg, July 2021] [TechCrunch, July 2021]. This capital infusion supported the scaling of its protein production platform. The company has since announced plans to begin public tastings of its animal-free mozzarella in 2025, marking its transition from R&D to initial product introduction [Breakthrough Energy Ventures Job Board, 2026].

Data Accuracy: GREEN -- Confirmed by company website, Crunchbase, and multiple press reports.

Product and Technology

MIXED The company's core proposition is a plant-based cheese that does not ask consumers to compromise on the functional properties of dairy. Nobell Foods, now operating under the parent brand Alpine Bio, engineers soybeans to produce dairy proteins, specifically casein, within the plant itself [Nobell Foods]. The resulting product is designed to melt, stretch, and taste like conventional cheese, a claim that directly addresses the primary consumer complaint against existing starch- and oil-based alternatives [Fast Company, July 2021]. The company frames its mission as serving the "99% of people who are unwilling to compromise on taste and price," positioning itself for the mainstream flexitarian market rather than a niche vegan audience [Y Combinator].

The patented technology platform involves modifying soybeans to express casein proteins, which the company calls "Cheesebeans™" [GFI, 2025]. After harvesting, the proteins are extracted and purified for use in cheese formulations. This molecular farming approach is distinct from both traditional animal agriculture and fermentation-based precision methods. The company claims the process uses 90% less water and land and generates 70% fewer emissions than conventional dairy production [Pear VC]. In 2024, the company harvested its first casein-containing soybeans, a key milestone in scaling its agricultural supply chain [GFI, 2025]. The first consumer-facing product is an animal-free mozzarella, with public tastings slated to begin in 2025 [Breakthrough Energy Ventures Job Board, 2026].

Beyond casein for cheese, the technology platform suggests potential expansion into other high-value dairy proteins. The company has noted it can also extract and purify lactoferrin, a bioactive milk protein, from engineered soybeans, indicating a pipeline that extends beyond consumer cheese to functional food ingredients [AgFunderNews, 2026]. The recent corporate rebranding to Alpine Bio, with Nobell Foods becoming a division, signals this broader platform ambition [AgFunderNews]. Regulatory progress is a current focus, with the company pursuing self-affirmed GRAS (Generally Recognized As Safe) status in the U.S. for its plant-derived casein [PUBLIC].

Data Accuracy: GREEN -- Product claims and technological approach are consistently described across company materials and multiple press reports. The 2025 tasting timeline and 2024 harvest milestone are reported by industry sources.

Market Research

PUBLIC The market for plant-based dairy is driven less by a niche vegan audience and more by the broad consumer demand for products that offer environmental and health benefits without sacrificing taste or price, a dynamic that has made the category a focal point for both consumer packaged goods companies and climate-focused investors.

The total addressable market for dairy alternatives is substantial, though specific TAM/SAM/SOM figures for Nobell Foods' plant-grown casein technology are not publicly disclosed in the cited research. Analysts typically reference the broader plant-based dairy category for context. According to a Bloomberg Intelligence report cited in July 2021 coverage of Nobell's funding, the global plant-based dairy market was projected to reach $62 billion by 2030, up from $21 billion in 2020 [Bloomberg, July 2021]. The cheese segment within this category is a key growth area, as it has historically lagged behind plant-based milk in replicating the sensory experience of its conventional counterpart.

Demand is shaped by several converging tailwinds. Consumer interest in reducing animal product consumption for environmental and health reasons continues to grow, creating a large addressable market of flexitarians rather than strict vegans. The company's own messaging targets the "99% of people who are unwilling to compromise on taste and price" [Y Combinator], indicating a strategy aimed at the mainstream. From an investor perspective, the climate impact of animal agriculture, particularly dairy, provides a significant mission-aligned capital tailwind, evidenced by participation from funds like Breakthrough Energy Ventures [SPEEDA Edge]. The technology's promise of using 90% less water and land while producing 70% fewer emissions, as cited by investor Pear VC, aligns directly with these environmental drivers.

The primary adjacent and substitute markets are instructive. The most direct adjacent market is the broader plant-based cheese category, which has been dominated by products made from starches, oils, and nuts. Nobell's approach competes within this space but aims to supersede it by solving the core functional deficiencies of melt and stretch. A key substitute market is conventional dairy cheese, a massive, entrenched industry where Nobell seeks to displace volume by offering an animal-identical product. Another adjacent space is the market for animal-identical proteins produced via fermentation, as practiced by competitors like Perfect Day, which represents a different technological path to a similar end product.

Regulatory pathways and consumer acceptance of novel ingredients are critical macro forces. The company is pursuing self-affirmed GRAS (Generally Recognized As Safe) certification in the US for its plant-derived casein, a necessary step for commercial food ingredient sales [AgFunderNews]. The regulatory landscape for genetically engineered crops and novel food proteins remains complex and varies by region, posing a potential headwind to global scaling. Furthermore, while the technology uses soybeans as a production platform, the final product is designed to be free of major allergens like lactose, though the use of a soybean platform and the production of milk proteins (allergens) in plants will require clear labeling and consumer education.

Global Plant-Based Dairy Market (2020) | 21 | $B
Global Plant-Based Dairy Market (2030 Projection) | 62 | $B

The projected near-tripling of the plant-based dairy market over a decade underscores the growth trajectory investors are betting on, though it masks the significant technical and commercial hurdles within the cheese segment that Nobell specifically aims to address.

Data Accuracy: YELLOW -- Market sizing figures are drawn from a third-party analyst report cited in contemporaneous news coverage. Specific TAM for Nobell's precise technology is not available.

Competitive Landscape

MIXED Nobell Foods, now operating as Alpine Bio, competes by aiming to produce animal-identical dairy proteins in plants, a technical approach that distinguishes it from both incumbent plant-based cheese makers and the fermentation-based precision dairy sector.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Nobell Foods (Alpine Bio)	Engineers dairy proteins (casein) directly in soybeans to create plant-based cheese with melt/stretch.	Series B; ~$103M total raised [Tracxn]	Patented molecular farming platform; targets cost parity and mainstream taste without fermentation.	[Nobell Foods] [Y Combinator]
Perfect Day	Uses precision fermentation to produce whey and casein proteins, sold as ingredients to CPG brands.	Later stage; $750M+ total funding [Crunchbase]	Commercialized B2B ingredient model; products (ice cream, protein powder) already on market.	[Perfect Day]
New Culture	Produces animal-free mozzarella using precision fermentation-derived casein.	Series A; $25M+ total funding [Crunchbase]	Focused exclusively on fresh mozzarella for pizza; targeting foodservice partnerships.	[New Culture]
Climax Foods	Uses data science and machine learning to formulate plant-based cheeses from diverse botanical inputs.	Series B; $25M+ total funding [Crunchbase]	AI-driven formulation platform; no genetic engineering; rapid product iteration from plants.	[Climax Foods]

The competitive map segments into three primary lanes. The first is the incumbent plant-based cheese category, dominated by brands like Miyoko's Creamery and Violife, which rely on blends of starches, oils, and nuts. These companies compete on brand, distribution, and improving organoleptic properties, but their products are fundamentally different in composition from dairy. The second lane is precision fermentation, led by Perfect Day and followed by New Culture and Remilk. These companies produce identical dairy proteins through microbial fermentation, a capital-intensive process that yields high-purity ingredients but faces scaling and regulatory costs. Alpine Bio occupies a third, emerging lane of molecular farming, where plants like soybeans are engineered to produce target proteins, potentially offering a capital-efficient, agricultural-scale production model [AgFunderNews, 2026].

Alpine Bio's current edge is its intellectual property around producing casein in soybeans and its capital position. The company holds multiple patents for its process and has secured over $100 million, a war chest that significantly outpaces most molecular farming peers [AgFunderNews]. This capital advantage is perishable, however, if it is not deployed to achieve regulatory milestones and pilot-scale production ahead of competitors. The technology edge is durable only if the company can demonstrate superior unit economics and scale relative to fermentation, a claim that remains unproven in public market deployments.

The company's most significant exposure is to the established fermentation pathway. Perfect Day has a multi-year headstart, with self-affirmed GRAS status, commercial manufacturing partnerships, and products on shelves. Its B2B ingredient model has already navigated key regulatory and supply chain hurdles that Alpine Bio is still approaching. Furthermore, Alpine Bio's reliance on genetically modified soybeans introduces a potential consumer perception and regulatory complexity not faced by botanical blend competitors like Climax Foods, which markets its products as non-GMO.

The most plausible 18-month scenario hinges on regulatory approval and initial product launches. If Alpine Bio successfully achieves self-affirmed GRAS for its casein and begins tastings of its mozzarella in 2025 as planned [Green Queen], it would validate the molecular farming approach and likely attract further partnership interest from large food companies seeking to de-risk their dairy supply chains. In this scenario, fermentation-focused players like New Culture, which is also targeting fresh mozzarella but with a more expensive production method, could lose ground on cost arguments. Conversely, if regulatory timelines slip or early product feedback is negative, the company's capital advantage erodes, and the winner would be the incumbent fermentation model, as Perfect Day continues to expand its protein portfolio and drive down costs through established fermentation scale-up playbooks.

Data Accuracy: YELLOW -- Competitor profiles and funding stages are confirmed via Crunchbase and company sources; differentiation claims are based on public positioning. Alpine Bio's specific technical and cost advantages versus fermentation are not yet independently verified with production data.

Opportunity

PUBLIC

If Nobell Foods (now Alpine Bio) can successfully scale its plant-grown casein platform and bring it to market at a competitive price point, the company is positioned to capture a significant portion of the $100+ billion global cheese market by offering a product that does not require consumers to compromise on taste or function [Bloomberg, July 2021].

The headline opportunity is to become the foundational ingredient supplier for the next generation of mainstream, animal-free dairy products, starting with cheese. Unlike startups focused on consumer brands, Alpine Bio's technology is a platform for producing animal-identical dairy proteins, primarily casein, directly in soybeans. This positions the company not as a niche plant-based cheese brand, but as a potential supplier to major food manufacturers and quick-service restaurant chains seeking to reduce their dairy footprint without alienating core customers. The plausibility of this outcome is grounded in the company's significant capital backing from investors like Breakthrough Energy Ventures and Andreessen Horowitz, its portfolio of ten U.S. patents protecting its protein expression and extraction processes, and its ongoing pursuit of self-affirmed GRAS (Generally Recognized as Safe) status, which is a critical regulatory step for an ingredient supplier [AgFunderNews, 2026] [GFI, 2025].

Growth is likely to follow one of several concrete, high-scale paths, each with identifiable catalysts.

Scenario	What happens	Catalyst	Why it's plausible
Ingredient Supplier to CPG Giants	Alpine Bio licenses its casein to multinational food companies (e.g., Kraft Heinz, Nestlé) for use in their existing cheese and dairy product lines, enabling them to launch hybrid or fully plant-based SKUs with minimal R&D.	Securing self-affirmed GRAS status for its casein, expected in the near term, followed by a publicly announced partnership with a major CPG player.	The company's rebranding from Nobell Foods to Alpine Bio explicitly signals a shift toward an ingredients and technology platform model, distancing itself from a consumer-facing brand [AgFunderNews, 2026]. Large food companies are actively seeking scalable, functional protein solutions to meet sustainability goals.
QSR & Foodservice Anchor	The company's animal-free mozzarella becomes the default cheese for a national pizza chain or fast-food burger brand, creating a high-volume, recurring revenue stream.	A pilot deployment of its mozzarella in a limited test market with a named restaurant partner in 2025, as indicated on its investor materials [Breakthrough Energy Ventures Job Board, 2026].	The product's stated goal is to match conventional cheese on melt and stretch,key functional attributes for pizza and burgers,at a competitive price point [Nobell Foods, Unknown]. This directly addresses the primary pain point for foodservice adoption of plant-based cheese.

Compounding success for Alpine Bio would be driven by a classic biotech and agriculture flywheel. Initial commercial sales, even at pilot scale, generate revenue to fund further R&D and process optimization. This leads to lower production costs per kilogram of protein, improving unit economics and expanding the addressable market to more price-sensitive categories. Simultaneously, scaling production volume increases the company's proprietary dataset on protein expression in soybeans across different growing conditions, which can be used to engineer higher-yielding, more resilient plant lines. This data and IP moat makes subsequent proteins (like lactoferrin) cheaper and faster to develop, transforming the platform from a single-protein company into a broad portfolio of animal-identical ingredients [AgFunderNews, 2026].

The size of the win can be framed by looking at comparable outcomes in adjacent food-tech sectors. Perfect Day, a pioneer in precision fermentation-derived whey protein, has raised over $800 million and achieved a multi-billion dollar valuation while partnering with major brands like Nestlé and General Mills [Crunchbase]. As an ingredient platform targeting the even larger casein-based cheese market, a successful execution of the Ingredient Supplier to CPG Giants scenario could position Alpine Bio for a similar valuation range within the next five to seven years. This represents a scenario, not a forecast, but it illustrates the magnitude of the opportunity if the company's technology and go-to-market strategy prove out.

Data Accuracy: YELLOW -- The core opportunity thesis is built on publicly stated company goals, investor backing, and patent filings. Specific catalysts like the 2025 tasting timeline are cited from a single source (investor job board). Market comparables are from public data.

Sources

PUBLIC

1. [Bloomberg, July 2021] Bill Gates-Backed Startup Makes Cheese Without Dairy Cows | https://www.bloomberg.com/news/articles/2021-07-06/bill-gates-backed-startup-makes-cheese-without-dairy-cows

2. [TechCrunch, July 2021] Nobell Foods raises $75M to make cheese from plants that produce dairy proteins | https://techcrunch.com/2021/07/06/nobell-foods-raises-

3. [Fast Company, July 2021] This startup just raised $75 million to make a more cheesy plant-based cheese | https://www.fastcompany.com/90657375/this-startup-just-raised-75-million-to-make-a-more-cheesy-plant-based-cheese

4. [Nobell Foods] Nobell Foods | https://www.nobellfoods.com/

5. [Y Combinator] Nobell Foods | https://www.ycombinator.com/companies/nobell-foods

6. [Tracxn] Nobell Foods | https://tracxn.com/d/companies/nobell-foods

7. [SPEEDA Edge] Nobell Foods | https://edge.speeda.com/companies/nobell-foods

8. [AgFunderNews] Molecular farming startup Nobell Foods rebrands as Alpine Bio, secures 10th US patent | https://agfundernews.com/exclusive-molecular-farming-startup-nobell-foods-rebrands-as-alpine-bio-secures-10th-us-patent

9. [Green Queen] Nobell Foods Rebrands to Alpine Bio, Aims to Launch Animal-Free Mozzarella in 2025 | https://www.greenqueen.com.hk/?p=72229

10. [GFI, 2025] Nobell Foods | https://gfi.org/resource/nobell-foods/

11. [Pear VC] Nobell Foods | https://www.pear.vc/portfolio/nobell-foods

12. [Breakthrough Energy Ventures Job Board, 2026] Nobell Foods | https://bevjobs.breakthroughenergy.org/companies/nobell-foods/jobs/37431812-pilot-plant-associate

13. [AgFunderNews, 2026] Plant-based cheesemaker Nobell Foods nets $75m from a16z, AgFunder & Breakthrough Energy | https://agfundernews.com/nobell-foods-nets-75m-from-a16z-agfunder-breakthrough-energy

14. [The Times Tech Podcast] Magi Richani | https://www.thetimes.com/podcasts/the-times-tech-podcast/magi-richani

15. [Crunchbase] Perfect Day | https://www.crunchbase.com/organization/perfect-day

16. [New Culture] New Culture | https://www.newculture.com/

17. [Climax Foods] Climax Foods | https://www.climaxfoods.com/

18. [Perfect Day] Perfect Day | https://perfectday.com/

19. [Crunchbase] New Culture | https://www.crunchbase.com/organization/new-culture

20. [Crunchbase] Climax Foods | https://www.crunchbase.com/organization/climax-foods